Changes in Peripheral Immune Cells after the Third Dose of SARS-CoV-2 mRNA-BNT162b2 Vaccine and Disease Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Prospective Analysis of the Vax-on-Third-Profile Study

SIMPLE SUMMARY: International standards recommend booster immunization against SARS-CoV-2 in advanced cancer patients undergoing active treatment. Little is known about the relationship between cell-mediated immune responses after vaccination and disease outcomes on immune checkpoint blockade. In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Nelli, Fabrizio, Signorelli, Carlo, Fabbri, Agnese, Giannarelli, Diana, Virtuoso, Antonella, Giron Berrios, Julio Rodrigo, Marrucci, Eleonora, Fiore, Cristina, Schirripa, Marta, Chilelli, Mario Giovanni, Primi, Francesca, Panichi, Valentina, Topini, Giuseppe, Silvestri, Maria Assunta, Ruggeri, Enzo Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377319/
https://www.ncbi.nlm.nih.gov/pubmed/37509286
http://dx.doi.org/10.3390/cancers15143625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377319/
https://www.ncbi.nlm.nih.gov/pubmed/37509286
http://dx.doi.org/10.3390/cancers15143625

Ejemplares similares